CLSTN3 and breast carcinoma: Although direct evidence on CLSTN3 protein and CRC risk is unreported, evidence from the human protein atlas has shown that high expression of CLSTN3 is favorable for prognostic of pancreatic cancer, breast cancer, and urothelial cancer [49].